|
KIAA0240 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62458935193399E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.59237076249974E-13 |
| Normal-vs-Stage2 |
7.13109999939121E-08 |
| Normal-vs-Stage3 |
2.37587727269783E-14 |
| Normal-vs-Stage4 |
6.91502410887779E-12 |
| Stage1-vs-Stage2 |
9.281200E-01 |
| Stage1-vs-Stage3 |
5.570300E-02 |
| Stage1-vs-Stage4 |
3.756400E-02 |
| Stage2-vs-Stage3 |
2.113000E-01 |
| Stage2-vs-Stage4 |
1.612780E-01 |
| Stage3-vs-Stage4 |
7.896400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.11022302462516E-16 |
| Normal-vs-AfricanAmerican |
8.04100000000307E-05 |
| Normal-vs-Asian |
1.1474999950245E-08 |
| Caucasian-vs-AfricanAmerican |
3.624000E-01 |
| Caucasian-vs-Asian |
5.229600E-01 |
| AfricanAmerican-vs-Asian |
6.777000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.67563748934663E-14 |
| Normal-vs-Female |
1.62658775337832E-12 |
| Male-vs-Female |
3.786200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.18820533809594E-11 |
| Normal-vs-Age(41-60Yrs) |
3.54161144855425E-14 |
| Normal-vs-Age(61-80Yrs) |
5.76161340859471E-12 |
| Normal-vs-Age(81-100Yrs) |
5.623500E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.888800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.742100E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.030200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.083000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.937000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.478400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.924500E-03 |
| Classical-VS-Follicular |
1.453210E-01 |
| Classical-VS-Other |
4.724200E-01 |
| Classical-VS-Normal |
3.3032000468225E-09 |
| Tall-VS-Follicular |
1.380990E-01 |
| Tall-VS-Other |
7.044400E-01 |
| Tall-VS-Normal |
1.22180043859998E-11 |
| Follicular-VS-Other |
8.463000E-01 |
| Follicular-VS-Normal |
1.25400023698319E-10 |
| Other-VS-Normal |
3.078000E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.47419878923938E-14 |
| Normal-vs-N1 |
1.68729474836482E-11 |
| N0-vs-N1 |
2.586600E-01 |
|
|
